Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination

Bibliographic Details
Main Authors:	Leelakrishna Channa, BS, Kristin Torre, MD, Marti Rothe, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	JAAD Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621004902

Similar Items

A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine
by: Natia Murvelashvili MD, et al.
Published: (2021-09-01)

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
by: Bryan Oronsky, et al.
Published: (2021-03-01)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
by: Alex Drohan, MD, et al.
Published: (2021-10-01)

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report
by: Ammar A. Hasnie, et al.
Published: (2021-08-01)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
by: Joshua Kaminetsky, et al.
Published: (2021-09-01)

Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients
by: Carl P. Herbort, et al.
Published: (2021-09-01)

Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination – report of three cases
by: Ioannis Papasavvas, et al.
Published: (2021-09-01)

New-onset chilblains in close temporal association to mRNA-1273 vaccination
by: Connie Kha, MD, et al.
Published: (2021-06-01)

Herpes Zoster Ophthalmicus
by: Shayna Adams, BS, et al.
Published: (2018-04-01)

Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
by: Pedro Rodríguez-Jiménez, MD, PhD, et al.
Published: (2021-06-01)

A rare case of herpes zoster ophthalmicus after photodynamic therapy
by: Madison Bradley, et al.
Published: (2020-12-01)

Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2
by: Ilir Alimehmeti
Published: (2021-01-01)

Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction
by: Norman-Philipp Hoff, et al.
Published: (2021-08-01)

The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization
by: Lorraine Sazgary, et al.
Published: (2021-06-01)

Varicella zoster virus reactivation and mRNA vaccines as a trigger
by: Iñigo Lladó, MD, et al.
Published: (2021-09-01)

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2
by: Mina Psichogiou, et al.
Published: (2021-06-01)

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
by: Joyce Kong, et al.
Published: (2021-10-01)

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
by: Baden, L.R, et al.
Published: (2022)

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
by: Cohen, K., et al.
Published: (2022)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Johnson, B., et al.
Published: (2022)

The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity
by: Sonia Tejedor Vaquero, et al.
Published: (2021-09-01)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
by: Chandravanshi Shivcharan, et al.
Published: (2009-01-01)

Reactivation of Herpes zoster in an adult with Plasmodium infection
by: Hariharan Regunath, et al.
Published: (2008-08-01)

Herpes Zoster Ophthalmicus in HIV/AIDS
by: Boateng Wiafe MD MSc
Published: (2003-01-01)

HERPES ZOSTER
by: Nowshad Khan
Published: (2014-09-01)

Herpes Zoster
by: Hamid Ehsani-Nia, et al.
Published: (2017-04-01)

Herpes zoster
by: Doughty, David Somerville
Published: (1895)

Herpes zoster
by: Papadopoulou, Ioanna
Published: (2013)

HERPES ZOSTER
by: Karin Kopitowski
Published: (1999-03-01)

Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
by: Yves Michiels, et al.
Published: (2021-08-01)

Cost-effectiveness of herpes zoster vaccination
by: Won Sriwijitalai, et al.
Published: (2019-01-01)

Herpes zoster after COVID vaccination
by: C.S. van Dam, et al.
Published: (2021-10-01)

Comparative effectiveness of BNT162B2 and mRNA-1273 vaccines in U.S. Veterans
by: Casas, J.P, et al.
Published: (2022)

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
by: Madison Ballman, BA, et al.
Published: (2021-10-01)

Accompanying Herpes Zoster with perichondritis-infectious auricle of chondritis
by: MH Taziki (MD), et al.
Published: (2000-09-01)

Hemorrhagic herpes zoster with contralateral multidermatomal distribution associated with rivaroxaban: An unusual presentation
by: Josiah Sowell, BS, et al.
Published: (2021-03-01)

Herpes zoster (Shingles)
by: M. H. Motswaledi
Published: (2018-08-01)

Herpes zóster dúplex
by: Marta Martínez-García, et al.
Published: (2020-11-01)

Herpes zoster ophthalmicus
by: Kavita R Bhatnagar
Published: (2013-01-01)

Pediatric Herpes Zoster
by: Daniel Quesada, et al.
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_li86rln6596ajvnsnlvcp9o4jn